https://www.selleckchem.com/pr....oducts/super-tdu.htm
procedure and fluoroscopy times even during the phase of the learning curve. ASPirin in Reducing Events in the Elderly (ASPREE), a randomized double-blind placebo-controlled trial (RCT) of daily low-dose aspirin (100 mg) in older adults, showed an increase in all-cause mortality, primarily due to cancer. In contrast prior RCTs, mainly involving younger individuals, demonstrated a delayed cancer benefit with aspirin. We now report a detailed analysis of cancer incidence and mortality. 19,114 Australian and U.S. community-dwelling parti
Curtir
Comentario
Compartilhar
